MRC1 and neoplasm: We found POLE mutations in two patients, MSI was estimated to be high in two cases, one additional case had a mutation in the MLH1 MMR gene, and TP53 mutations were found in three tumours, which is the same number as for tumours with CTNNB1 mutations.